Plus Therapeutics, Inc (PSTV) Stock Price

5.25 ▼ -0.51 (-8.85%)
Open: 5.57 Vol: 171.16K Day's range: 5.05 - 5.67 May 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PSTV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 5.22▲ 5.21▲ 5.19▲ 5.72▼ 6.09▼
MA10 5.20▲ 5.19▲ 5.42▼ 5.92▼ 3.95▲
MA20 5.24▲ 5.41▼ 5.58▼ 6.24▼ 2.14▲
MA50 5.55▼ 5.73▼ 5.91▼ 3.60▲ 1.17▲
MA100 5.83▼ 5.87▼ 6.08▼ 1.98▲ 1.19▲
MA200 5.87▼ 6.25▼ 5.39▼ 1.28▲ 2.58▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.027▲ 0.003▲ -0.038▼ -0.285▼ 0.547▲
RSI 42.770▼ 40.031▼ 35.659▼ 49.011▼ 74.210▲
STOCH 83.654▲ 42.251     12.009▼ 30.257     81.300▲
WILL %R -10.526▲ -79.268▼ -79.268▼ -87.499▼ -34.938    
CCI 91.000     -24.002     -64.228     -216.002▼ 69.911    
Latest Filters Detected On PSTV
RSI $PSTV RSI(14) Crossed Below 50 Set Alert
▼ GAP $PSTV Open Gap Down %3 Set Alert
▼ GAP $PSTV Open Gap Down %2 Set Alert
▼ BREAK $PSTV Price Breaks 20 Days Low Set Alert
▼ BREAK $PSTV Price Breaks 10 Days Low Set Alert
Plus Therapeutics, Inc News
Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout
Friday, May 15, 2026 01:27 PM
Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) ...
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
Thursday, May 14, 2026 09:46 AM
CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin glioblastoma story. But here’s what you should actually be watching. Holders ...
Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in ...
Friday, May 08, 2026 04:56 AM
Plenary session at AANS underscores REYOBIQ’s potential as a differentiated targeted radiotherapeutic platform for CNS cancersHOUSTON, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc.
PSTV historical stock data
date open high low close volume
15/05/26 5.57 5.67 5.05 5.25 171,160
14/05/26 5.70 5.93 5.30 5.76 160,351
13/05/26 5.82 5.90 5.67 5.70 111,456
12/05/26 5.99 6.01 5.75 5.85 82,179
11/05/26 6.07 6.24 5.90 6.04 134,213
08/05/26 6.04 6.30 5.82 6.12 106,553
07/05/26 6.28 6.45 5.8233 5.95 109,601
06/05/26 6.05 6.15 5.85 6.00 175,945
05/05/26 6.44 6.5774 6.195 6.22 101,568
04/05/26 6.00 6.6499 6.00 6.30 135,899
Quote Details
52wk Low:0.129
52wk High:8.00
Vol:171.16K
Avg Vol(3m):44.4M
1Y Chng:+1,285.59%
1M Chng:+57.66%
Add to Watch List
More Information
Index US Composite
Market Cap. 39.53M